Clinical chemistry biological screening IVDs
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
02-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Bayer Australia Ltd
Class:
Class 3
Manufactured by:
Peptonic Medical Israel Ltd Haeshel St 7, Caesarea, 3088900 Israel
Therapeutic area:
CT1236 - Clinical chemistry biological screening IVDs
Therapeutic indications:
This self-test IVD is an indicator for abnormal vaginal discharge caused by bacterial or parasitic infections. This IVD determines whether there is a high or a low risk of bacterial or parasitic infections by indicating disordered acidity parameters.
Authorization status:
A
Authorization date:
2017-09-22
